Metformin × blood pressure

TrialCardiovascular diabetology2020

Metformin may adversely affect orthostatic blood pressure recovery in patients with type 2 diabetes: substudy from the placebo-controlled Copenhagen Insulin and Metformin Therapy (CIMT) trial.

Christian Stevns Hansen et al.PubMed ↗Full text ↗Publisher ↗

What the trial testedrandomised · 412 people · 2020

Randomised comparison

Probably raised blood pressure

+3.40mmHg+0.60 to +6.20

As reported

difference 3.4 mmHg, 95% CI 0.60–6.20

Randomised comparison

Probably raised blood pressure

+1.30mmHg+0.30 to +2.60

As reported

difference 1.3 mmHg, 95% CI 0.30–2.60

Two numbers in the abstract

the abstract, start to end

blood pressure drop increased by 3.4 mmHg (95% CI 0.6; 6.2, p = 0.02) and diastolic blood pressure drop increased by 1.3 mmHg (95% CI 0.3; 2.6,

← favours treatmentfavours comparator →
could be chance
Blood pressure
3.40.60–6.20
Blood pressure
1.30.30–2.60
MetforminBlood pressure

Metformin × blood pressurehelps?mixed

unlikelylikely
0.400.50 without it
← favours treatmentfavours comparator →
this papermore certainless certain
1 / 5

7 papers cite it

2020
2021
2022
2023
2024
2025
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 32979921